Education
About Us
Working with TipRanks
Follow Us
Evgen Pharma PLC (GB:TCF)
LSE:TCF
Total Valuation
Evgen Pharma has a market cap or net worth of £5.05M. The enterprise value is 5.17M.
Market Cap£5.05M
Enterprise Value5.17M
Share Statistics
Evgen Pharma has 2,148,963,600 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,148,963,600
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Evgen Pharma’s return on equity (ROE) is -1.34 and return on invested capital (ROIC) is -133.78%.
Return on Equity (ROE)-1.34
Return on Assets (ROA)-1.02
Return on Invested Capital (ROIC)-133.78%
Return on Capital Employed (ROCE)-1.52
Revenue Per Employee44.00K
Profits Per Employee-396.22K
Employee Count9
Asset Turnover0.13
Inventory Turnover-11.00
Valuation Ratios
The current PE Ratio of Evgen Pharma is -0.74. Evgen Pharma’s PEG ratio is -0.05.
PE Ratio-0.74
PS Ratio0.00
PB Ratio1.90
Price to Fair Value1.00
Price to FCF-2.52
Price to Operating Cash Flow-2.52
PEG Ratio-0.05
Income Statement
In the last 12 months, Evgen Pharma had revenue of 396.00K and earned -3.14M in profits. Earnings per share was -0.01.
Revenue396.00K
Gross Profit385.00K
Operating Income-3.56M
Pretax Income-3.57M
Net Income-3.14M
EBITDA-3.55M
Earnings Per Share (EPS)-0.01
Cash Flow
In the last 12 months, operating cash flow was -3.12M and capital expenditures 0.00, giving a free cash flow of -3.12M billion.
Operating Cash Flow-3.12M
Free Cash Flow-3.12M
Free Cash Flow per Share>-0.01
Dividends & Yields
Evgen Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.63
52-Week Price Change-75.51%
50-Day Moving Average0.24
200-Day Moving Average0.52
Relative Strength Index (RSI)36.36
Average Volume (3m)2.96M
Important Dates
Evgen Pharma upcoming earnings date is Dec 18, 2025, TBA Not Confirmed.
Last Earnings DateJun 3, 2025
Next Earnings DateDec 18, 2025
Ex-Dividend Date―
Financial Position
Evgen Pharma as a current ratio of 4.20, with Debt / Equity ratio of 0.00%
Current Ratio4.20
Quick Ratio4.20
Debt to Market Cap0.00
Net Debt to EBITDA0.56
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Evgen Pharma has paid -429.00K in taxes.
Income Tax-429.00K
Effective Tax Rate0.12
Enterprise Valuation
Evgen Pharma EV to EBITDA ratio is -0.09, with an EV/FCF ratio of -0.11.
EV to Sales0.84
EV to EBITDA-0.09
EV to Free Cash Flow-0.11
EV to Operating Cash Flow-0.11
Balance Sheet
Evgen Pharma has £1.20M in cash and marketable securities with £0.00 in debt, giving a net cash position of -£1.20M billion.
Cash & Marketable Securities£1.20M
Total Debt£0.00
Net Cash-£1.20M
Net Cash Per Share>-£0.01
Tangible Book Value Per Share<£0.01
Margins
Gross margin is 97.06%, with operating margin of -898.99%, and net profit margin of -792.17%.
Gross Margin97.06%
Operating Margin-898.99%
Pretax Margin-900.51%
Net Profit Margin-792.17%
EBITDA Margin-896.21%
EBIT Margin-898.99%
Analyst Forecast
The average price target for Evgen Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-100.00%
EPS Growth Forecast26.23%